Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Merck & Company (MRK)

Merck & Company (MRK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Worldwide Nanomedicines Industry to 2026 - Featuring 3M, Thermo Fisher Scientific and Eli Lily & Co Among Others

/PRNewswire/ -- The report has been added to offering.

AZN : 58.68 (-0.14%)
CELGZ : 0.47 (+2.15%)
MRK : 75.08 (-0.49%)
PFE : 39.52 (-0.28%)
SNN : 43.76 (-0.57%)
Glaxo (GSK)/iTeos Therapeutics to Co-Develop Novel Cancer Drug

Glaxo (GSK) signs deal with iTeos Therapeutics to co-develop its investigational cancer candidate known as EOS-448. Glaxo will also study EOS-448 with its other investigational cancer therapies.

GSK : 40.47 (-0.05%)
RHHBY : 47.8600 (+0.42%)
MRK : 75.08 (-0.49%)
ITOS : 26.10 (-5.09%)
AtriCure Names Two New Members to the Board of Directors

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that Deborah H. Telman and Maggie Yuen have been...

ATRC : 78.81 (+2.54%)
OGN : 30.41 (+0.43%)
MRK : 75.08 (-0.49%)
SRNE : 8.97 (-5.18%)
JCI : 66.32 (+0.24%)
ABT : 110.62 (+0.13%)
BA : 245.47 (+0.13%)
PEN : 275.19 (-0.80%)
TMO : 470.11 (+0.01%)
BSX : 42.44 (-0.24%)
Membrane Chromatography Market to Reach USD 635 Million Revenue by 2027 at 17.5% CAGR, Predicts Market Research Future (MRFR)

As per Market Research Future (MRFR), the Global Membrane Chromatography Market is anticipated to achieve USD 635 Million by 2027 at a 17.5% CAGR. The development in the pharmaceutical industry has contributed...

AHKSF : 11.4100 (-1.13%)
MRK : 75.08 (-0.49%)
SARTF : 475.0000 (-1.04%)
KVK is pleased to announce the appointment of Ram Kamineni as Chief Operating Officer

/PRNewswire/ -- KVK-Tech, Inc. (KVK) and its affiliate Penn Life Sciences, Inc. (PLS) have announced that they have appointed Ram Kamineni as Chief Operating Officer, effective .

MRK : 75.08 (-0.49%)
NVS : 93.89 (+0.32%)
Immunology Market to Hit USD 158.69 Billion with 8.1% CAGR by 2028 Backed by Increasing Demand for Biosimilars Globally, reports Fortune Business Insights(TM)

Global Immunology Market Size| 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional...

AGN : 193.02 (+0.02%)
AMGN : 239.76 (-0.59%)
MRK : 75.08 (-0.49%)
NVS : 93.89 (+0.32%)
PFE : 39.52 (-0.28%)
UCBJF : 96.6500 (-0.28%)
Bristol Myers (BMY) Announces Data on CAR T Cell Therapy Breyanzi

Bristol Myers (BMY) announces positive data on CAR T cell therapy, Breyanzi, in the second-line setting for patients with relapsed or refractory large B-cell lymphoma.

BMY : 67.25 (-0.06%)
MRK : 75.08 (-0.49%)
RGEN : 190.94 (-2.15%)
BLUE : 32.98 (-1.64%)
Stock Market News for Jun 11, 2021

Benchmarks closed in the green as investors shrugged off inflation report in agreement with the Fed's argument that jump in prices is temporary as demand exceed supply on account of the economy's recovery...

MRK : 75.08 (-0.49%)
ALGN : 603.60 (-0.36%)
ILMN : 448.56 (-0.79%)
ADBE : 550.87 (-1.09%)
SPLK : 122.24 (-0.12%)
MELI : 1,436.60 (+0.28%)
WBA : 54.42 (-0.02%)
Electronic Chemicals Market Size, Growth | Global Report Analysis For Upcoming Years

Japan, Japan, Fri, 11 Jun 2021 07:33:17 / Comserve Inc. / -- Electronic Chemicals Market With Top Countries Data, Industry Analysis , Size, Share, Revenue, Prominent Players, Developing Technologies,...

AIQUY : 34.9100 (+2.14%)
APD : 300.02 (+0.30%)
ASH : 92.02 (-0.03%)
CCMP : 156.23 (-1.49%)
HCHMF : 41.5000 (+10.23%)
HON : 222.62 (-0.25%)
JSCPF : 30.1288 (-4.35%)
LNEGY : 37.1825 (+9.04%)
MRD : 14.72 (+0.20%)
MRK : 75.08 (-0.49%)
SOMMF : 5.6700 (-1.22%)
WKCMF : 166.7500 (-2.15%)
Resorbable (Bioresorbable) Polymers Market Size, Share & Growth | Analysis for Upcoming Years

Japan, Japan, Fri, 11 Jun 2021 07:38:53 / Comserve Inc. / -- Resorbable (Bioresorbable) Polymers Market With Top Countries Data, Industry Analysis , Size, Share, Revenue, Prominent Players, Developing...

EVKIY : 17.6100 (-0.34%)
MRK : 75.08 (-0.49%)
Pharma Stock Roundup: FDA Approval for NVO, PFE Products & Other Updates

FDA approves Novo Nordisk's (NVO) obesity treatment, Wegovy and Pfizer's (PFE) 20-valent pneumococcal conjugate vaccine, Prevnar 20.

NVS : 93.89 (+0.32%)
PFE : 39.52 (-0.28%)
NVO : 84.68 (+0.30%)
MRK : 75.08 (-0.49%)
LLY : 223.19 (-1.29%)
BNTX : 216.54 (-1.83%)
Merck (MRK) Signs $1.2B Deal With US for COVID-19 Therapeutic

Merck (MRK) is set to supply 1.7 million courses of its oral COVID-19 therapy candidate, molnupiravir, worth $1.2 billion to the U.S. government, following a potential approval or authorization.

JNJ : 164.90 (-0.28%)
RHHBY : 47.8600 (+0.42%)
PFE : 39.52 (-0.28%)
MRK : 75.08 (-0.49%)
Transcarent Raises $58 Million in Series B Funding to Accelerate Consumer-Directed Health and Care Experience for Self-Insured Employers

Transcarent, a new and different consumer-directed health and care experience for employees of self-insured employers and their families, today announced a $58 million Series B investment led by General...

MRK : 75.08 (-0.49%)
Multiple Sclerosis Drugs Market to Reach USD 41.99 Billion by 2028; Rising Support from Governments and Launch of Awareness Initiatives to Aid Growth: Fortune Business Insights(TM)

The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to discover innovative and effective therapies for the treatment...

MRK : 75.08 (-0.49%)
NVS : 93.89 (+0.32%)
PFE : 39.52 (-0.28%)
TEVA : 10.98 (-0.63%)
TSX Drops to Even 20K

Canada's main stock index opened lower on Wednesday as financial stocks declined following the central ...

MRK : 75.08 (-0.49%)
Pfizer (PFE) Gets FDA Nod for Pneumococcal Vaccine Prevnar 20

Pfizer's (PFE) 20-valent pneumococcal conjugate vaccine candidate helps protect against 20 serotypes responsible for the majority of invasive pneumococcal disease and pneumonia.

PFE : 39.52 (-0.28%)
MRK : 75.08 (-0.49%)
BAYRY : 16.2502 (+0.19%)
BNTX : 216.54 (-1.83%)
Merck Announces Supply Agreement with U.S. Government for Molnupiravir, an Investigational Oral Antiviral Candidate for Treatment of Mild to Moderate COVID-19

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it has entered into a procurement agreement with the United States government for molnupiravir (MK-4482). Molnupiravir...

MRK : 75.08 (-0.49%)
Antivirals Global Market Report 2021: COVID 19 Implications And Growth to 2030

Reportlinker.com announces the release of the report "Antivirals Global Market Report 2021: COVID 19 Implications And Growth to 2030" - https://www.reportlinker.com/p06090622/?utm_source=GNW

ABBV : 115.15 (-0.22%)
GILD : 67.96 (-0.28%)
GSK : 40.47 (-0.05%)
MRK : 75.08 (-0.49%)
Fertility Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Reportlinker.com announces the release of the report "Fertility Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06090623/?utm_source=GNW

MRK : 75.08 (-0.49%)
PG : 135.21 (+0.22%)
Oligonucleotide Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030

Reportlinker.com announces the release of the report "Oligonucleotide Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030" - https://www.reportlinker.com/p06090627/?utm_source=GNW

DVAX : 8.48 (-5.99%)
IONS : 36.97 (-2.17%)
JAZZ : 186.84 (+0.23%)
MRK : 75.08 (-0.49%)
MGEN : 23.01 (-0.09%)
SRPT : 85.06 (-1.23%)

Barchart Exclusives

WASDE Selling In Grains And Oilseed Futures- The Weather Is Critical For The Coming Months
The monthly WASDE report came out last week, and grain and oilseed futures prices declined in the wake of the report. The most significant factor for the coming weeks and months is the weather conditions that will determine supply levels during the 2021 harvest season. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar